180 related articles for article (PubMed ID: 17314145)
1. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
De Rojas MV; Dart JK; Saw VP
Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
[TBL] [Abstract][Full Text] [Related]
2. Topical Betamethasone Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Ocular Involvement in the Acute Phase.
Matsumoto K; Ueta M; Inatomi T; Fukuoka H; Mieno H; Tamagawa-Mineoka R; Katoh N; Kinoshita S; Sotozono C
Am J Ophthalmol; 2023 Sep; 253():142-151. PubMed ID: 37182731
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Kwan J; Ahmed H; Ponsetto MK; Succar T; Chodosh J; Saeed HN
Ocul Immunol Inflamm; 2023 Jul; 31(5):900-904. PubMed ID: 35486647
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Assessment of Long-Term Complications in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Cekic S; Canitez Y; Yuksel H; Ucan Gunduz G; Karali Z; Yalcinbayir O; Vural P; Sapan N
Int Arch Allergy Immunol; 2023; 184(10):994-1002. PubMed ID: 37494888
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Treatment of Ophthalmic Sequelae of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at a Tertiary Eyecare Centre in Hungary.
Tóth G; Lukács A; Stachon T; Schirra F; Sándor GL; Nagy ZZ; Szentmáry N
Ophthalmol Ther; 2024 May; 13(5):1343-1356. PubMed ID: 38507192
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Shanbhag SS; Rashad R; Chodosh J; Saeed HN
Am J Ophthalmol; 2019 Dec; 208():331-341. PubMed ID: 31326519
[TBL] [Abstract][Full Text] [Related]
7. Microbial Keratitis in Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Experience From a Tertiary Centre in Taiwan.
Tsai TY; Adiyabazar D; Hsiao CH; Pan LY; Chen SY; Tsai YJ; Chen CB; Chung WH; Ma DH
Cornea; 2023 Jan; 42(1):66-73. PubMed ID: 35587449
[TBL] [Abstract][Full Text] [Related]
8. Ocular Manifestations and Outcomes in Children With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Comparison With Adult Patients.
Chen YL; Tsai TY; Pan LY; Tsai YJ; Chen SY; Hsiao CH; Yeh LK; Tan HY; Chen HC; Hung KH; Quan W; Chen CB; Chung WH; Ma DH
Am J Ophthalmol; 2023 Dec; 256():108-117. PubMed ID: 37633318
[TBL] [Abstract][Full Text] [Related]
9. Chronic ocular complications in lamotrigine vs. trimethoprim-sulfamethoxazole induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Rashad R; Shanbhag SS; Kwan J; Chodosh J; Saeed S; Saeed HN
Ocul Surf; 2021 Jul; 21():16-18. PubMed ID: 33932610
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States.
Moreau JF; Watson RS; Hartman ME; Linde-Zwirble WT; Ferris LK
Pediatr Dermatol; 2014; 31(2):163-8. PubMed ID: 23679157
[TBL] [Abstract][Full Text] [Related]
11. Diphtheroids as Corneal Pathogens in Chronic Ocular Surface Disease in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Shanbhag SS; Shih G; Bispo PJM; Chodosh J; Jacobs DS; Saeed HN
Cornea; 2021 Jun; 40(6):774-779. PubMed ID: 33758140
[TBL] [Abstract][Full Text] [Related]
12. Sutureless Amniotic Membrane (ProKera®) and Intravenous Immunoglobulin in the Management of Ocular Complications of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Overlap.
Mahmood AH; Alharbi AS; Almanea BA; Alsaati AF
Cureus; 2021 Aug; 13(8):e16989. PubMed ID: 34540392
[TBL] [Abstract][Full Text] [Related]
13. The effects of systemic cyclosporine in acute Stevens-Johnson syndrome/toxic epidermal necrolysis on ocular disease.
Hall LN; Shanbhag SS; Rashad R; Chodosh J; Saeed HN
Ocul Surf; 2021 Jan; 19():128-132. PubMed ID: 32445836
[TBL] [Abstract][Full Text] [Related]
14. Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom.
Radford CF; Rauz S; Williams GP; Saw VP; Dart JK
Eye (Lond); 2012 Sep; 26(9):1199-208. PubMed ID: 22722485
[TBL] [Abstract][Full Text] [Related]
15. Sutureless Amniotic Membrane Transplantation Using Pediatric Nasogastric Tube for Patients With Acute Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Ceylan A; Mergen B; Aydin FO; Avci E; Yildirim Y
Eye Contact Lens; 2023 May; 49(5):199-203. PubMed ID: 36943174
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcome of Amniotic Membrane Transplant in Ocular Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis at a Major Burn Unit.
Mortensen XM; Shenkute NT; Zhang AY; Banna H
Am J Ophthalmol; 2023 Dec; 256():80-89. PubMed ID: 37598739
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-driven and interleukin-36γ-associated ocular surface inflammation in chronic Stevens-Johnson syndrome.
Koduri MA; Pingali T; Prasad D; Singh V; Singh S; Shanbhag SS; Basu S; Singh V
Allergy; 2024 Apr; ():. PubMed ID: 38682250
[TBL] [Abstract][Full Text] [Related]
18. Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A National Survey in Japan.
Kojima M; Mieno H; Ueta M; Nakata M; Teramukai S; Sunaga Y; Ochiai H; Iijima M; Kokaze A; Watanabe H; Kurosawa M; Azukizawa H; Asada H; Watanabe Y; Yamaguchi Y; Aihara M; Ikezawa Z; Mizukawa Y; Ohyama M; Shiohara T; Hama N; Abe R; Hashizume H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Hashimoto K; Takahashi H; Niihara H; Morita E; Sueki H; Kinoshita S; Sotozono C
Am J Ophthalmol; 2024 May; ():. PubMed ID: 38795750
[TBL] [Abstract][Full Text] [Related]
19. Unique cytokine signature in ocular Stevens-Johnson syndrome non-responders.
Gurumurthy S; Srinivasan B; Agarwal S; Matai H; Angayarkanni N; Iyer G
Ocul Surf; 2024 Apr; 32():173-181. PubMed ID: 38490474
[TBL] [Abstract][Full Text] [Related]
20. Elevated neutrophils and reduced NK cells are associated with altered tear molecular signatures and clinical sequelae of chronic ocular Stevens-Johnson syndrome.
D'Souza S; Nair AP; Ashok N; Kannan R; Dickman MM; Nuijts RMMA; Shetty R; Sethu S; Ghosh A
Ocul Surf; 2024 May; 34():9-21. PubMed ID: 38703818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
